
TL;DR: A 2026 meta-analysis in Sleep and Breathing found that GLP-1 drugs, metabolic hormone medications involved in glucose, appetite, and weight regulation, were linked to fewer obstructive sleep apnea breathing events in adults with obesity. Key Findings Sl…
Read article ↗
Semaglutide is emerging as a wonder drug for management of various metabolic diseases. Originally approved for type 2 diabetes, this glucagon like peptide-1 (GLP-1) receptor agonist is now showing promise for treating obesity, non-alcoholic steatohepatitis (NA…
Read article ↗
Obesity has reached epidemic levels globally, with serious health and economic consequences. While lifestyle factors play a key role, genetics also influence a person’s susceptibility to weight gain or difficulty losing weight. An emerging field called pharmac…
Read article ↗
A new randomized, double-blind, placebo-controlled clinical trial provides evidence that a green coffee bean extract standardized to chlorogenic acids (CGA-7) can help with weight loss in healthy overweight adults. Key facts: CGA-7 supplementation for 12 weeks…
Read article ↗
A new systematic review and meta-analysis suggests that swapping out sugar-sweetened beverages (SSBs) for low- and no-calorie sweetened beverages (LNCSBs) may support modest weight loss and improve certain cardiometabolic factors. The study found that LNCSBs o…
Read article ↗
Obesity has been linked to faster brain aging, but can losing weight turn back the clock? A new study provides compelling evidence that shedding pounds through lifestyle changes may attenuate brain aging. Key facts: Participants lost an average of 5% of body w…
Read article ↗